RecruitingNot Applicable

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

United States128 participantsStarted 2021-08-09

Plain-language summary

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM. * Female participants of childbearing potential will be required to provide a negative pregnancy test. * Ability to understand and teach back consent for the procedure. * Willingness to sign consent for procedure. * English speaking. Exclusion Criteria: * Emergent surgery status. * Local infection * Allergy to local anesthetics. * Recreational drug use. * Inability to provide informed consent. * Pregnancy or breastfeeding. * History of Guillain-Barre' Syndrome. * Underlying medical conditions that would post a significant risk to the patient. * Opioid use \>90 days in the year leading up to surgery.

What they're measuring

Opioid consumption (MME)

Timeframe: First 24 hours postoperative

Trial details

NCT IDNCT05024344

SponsorUniversity of Tennessee Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12-31

Contact for this trial

Jason Buehler, MD

865-305-9220 jbuehler@utmck.edu